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SPECIFIC AIMS  
     It is well-established that long term calorie restriction (CR) has many beneficial effects, 
however, research has shown that adherence to long term CR is low.  Alternate day fasting (ADF) 
is a diet regimen that has emerged as a possibly more viable alternative to traditional CR models 
because subjects are not required to restrict calories every day.  Studies have shown ADF to have 
many of the same physiologic benefits as CR, including the improvements of biomarkers of some 
chronic diseases. 
     The small intestine is one of the first organs exposed to digested nutrients and is lined with a 
monolayer of intestinal epithelial cells of which are highly renewable.  Because the intestinal 
epithelium is vital in the digestion and absorption of nutrients, we are interested in understanding 
how it is impacted by the recently popularized, ADF diet regimen.  The following aims will test 
a central hypothesis that ADF will have similar protective effects as CR in metabolic and 
intestinal parameters.  
     AIM 1 will assess the effects of ADF on overall metabolic markers and phenotype.  CD-1 
mice will be randomly divided into one of two groups: ADF, fed ad libitum for 24 hours followed 
by removal of food for the next 24 hours, or control, fed ad libitum.  The designated diet will be 
administered for 20 weeks.  During the diet, food intake will be measured by weighing the amount 
of food remaining in the cage after feeding.  After 20 weeks, body weight, fat mass, and plasma 
triglyceride levels will be measured.  We hypothesize ADF mice will adapt to ADF by 
decreasing body weight, fat mass, and plasma triglycerides.  
     AIM 2 will assess the effects of ADF on the intestinal epithelium.  Fasting and refeeding 
studies show the rapid effect of nutrients on crypt-villus morphology.  Therefore, we will measure 
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crypt depth, villus height, and crypt cell number in ADF and control animals.  We hypothesize 
ADF will impact the crypt-villus axis by decreasing villus height and crypt depth.  
     Proliferation of the intestinal epithelium will be analyzed.  To do this, the number of 
proliferating cells and mRNAs of genes implicated in pathways known to impact intestinal 
proliferation will be measured.  We hypothesize there will be a decrease in cell proliferation 






Calorie restriction has been shown to have many physiologic benefits that can reduce 
chronic disease risk.  A possibly more feasible alternative to the calorie restriction model is the 
alternate day fasting (ADF) regimen, consisting of giving food ad libitum for 24 hours followed 
by withholding food for 24 hours.  ADF has also been shown to decrease cell proliferation in 
several different tissues.  Currently, the effect of ADF on the intestine, the initial site of nutrient 
absorption, is unknown.  We hypothesized that ADF would decrease proliferation in the intestinal 
epithelium leading to changes in gene expression associated with changes in intestinal growth and 
metabolism. CD-1 mice were fed standard chow ad libitum or ADF for 20 weeks.  Body weight 
did not differ between groups, however, ADF mice displayed 60% lower gonadal fat mass and no 
detectable mesenteric fat compared to controls.  There were no significant changes in villus height 
between groups, however, there was a 12% decrease in crypt depth associated with 13% fewer 
total cells per crypt in ADF mice compared to controls.  Proliferation assessed by EdU (S-phase) 
was decreased by 20% in ADF mice compared to controls.  To analyze ADF impact on the 
IGF1/insulin pathway, which promotes intestinal proliferation, mRNA levels of Igf1, Igf1r, Ir, 
Gcg, and Ccnd1 were measured.  A trend for decrease of mRNA levels was found for all genes in 
the jejunum, while significant decreases of Igf1, Igf1r, Ir, and Ccnd1 were found in the colon.  
Measurements of mRNA levels for the insulin receptor (IR) isoforms, IR-A and IR-B, showed 
significantly increased IR-B:IR-A ratio in the jejunum and colon.  Taken together, our data suggest 
despite similar caloric intake, ADF mice may limit intestinal proliferation by up-regulating IR-B 






 Calorie restriction (CR), a form of dietary restriction where caloric intake is reduced by 
15-40% without risk of malnutrition, has been shown to reduce risk of chronic disease and 
demonstrate life-extending properties.  Both animal and human studies have demonstrated it 
improves insulin sensitivity,1, 2 cardiovascular health,3-5 and protects against oxidative stress.6-9  
However, a more recently studied and popularized diet regimen, alternate day fasting (ADF), is 
thought to be a more feasible alternative to CR.  In animal studies, ADF diet regimens have shown 
similar physiological benefits to those seen in CR in improving biomarkers of type 2 diabetes,10-12 
cardiovascular disease,12-14 and cancer.12, 15-17 
ADF regimens consist of giving food ad libitum for 24 hours, followed by no food or 
reduced food intake during the next 24 hours.  This pattern is then continuously repeated.  A 
significant difference between ADF and CR is that overall caloric intake is typically not reduced 
in the ADF regimen, as mice tend to gorge on food during feed days.  During the 24 hour ad libitum 
feeding in the ADF diet, food intake is significantly increased to the extent that overall caloric 
intake of the ADF subject is equivalent to that of a control during the same length of time.  
Therefore, the significance of the ADF diet regimen is the pattern in which the food is consumed, 
not the amount.  Although ADF has been less studied than CR, the ADF diet regimen has also 
been shown to produce many physiological benefits that play a role in reducing chronic disease 
risk.  Decreases in circulating glucose concentrations have been reported in animals after 20-24 
weeks on the ADF diet regimen,18, 19 with one of the studies finding a reduction of glucose and 
insulin levels in the ADF treatment groups similar to the reduction seen in 40% CR treatment 
groups.18  Improved insulin sensitivity in humans has also been shown, after 2 weeks of ADF 
intervention.20  Animals had reduced heart rate and blood pressure following 16 weeks of an ADF 
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diet regimen, which again was similar to the reduction shown in 40% CR treatment groups.21  The 
cardiovascular benefits have been less conclusive in humans, however, one study found that after 
3 weeks of ADF treatment, human subjects had increased circulating HDL cholesterol and 
decreased circulating TAG.22  The relationship between ADF and cancer risk factors have only 
been studied in animals, but many physiological changes associated with ADF have shown 
protective effects against cancer.23-25  Although many physiologic changes have been observed 
after ADF dietary interventions, the mechanisms in which these changes occur is not well defined.  
Another effect that has been observed after treatment with ADF is decreased cell 
proliferation.  In the study performed by Varady et al, mice had decreased proliferation of 
epidermal, splenic T, and mammary epithelial cells after a 4 week ADF diet regimen.26  Similar 
results were replicated in another study, which showed reduced proliferation of epidermal, 
prostate, liver, and splenic T cells.27  To analyze cell proliferation in both studies, deuterium label 
enrichment in DNA isolated from the different cell types was measured.  Effects of ADF on overall 
intestinal physiology or intestinal epithelial proliferation have yet to be explored.  
Upon ingestion of food, the small intestine is the first organ exposed to the digested 
nutrients.  The intestinal epithelium, the initial site of intestinal absorption, is highly renewable 
which allows it to respond and adapt to changes in nutrition.  Studies in rats have shown fasting 
promotes mucosal atrophy as early as 48-72 hours following the start of fasting, while 24 hour 
refeeding then induces intestinal growth and reverses the effects of fasting.28, 29  The highly 
renewable capacity of the intestinal epithelium is driven by the intestinal epithelial stem cells 
(IESC), located at the base of the intestinal crypt, while the villus serves as the functional unit 
predominately consisting of absorptive enterocytes (Fig 1).  IESC divide to self-renew and give 
rise to daughter progenitor cells, which undergo rapid multiple cell divisions before differentiating 
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into one of four lineages: absorptive enterocytes, secretory Paneth, goblet, or enteroendocrine cells 
(EEC). Previous studies in Drosophila have shown that IESC respond to changes in fasting and 
refeeding by altering cell number and proliferation.30, 31  Effects of ADF dietary interventions on 
the intestinal epithelium and IESC have yet to be defined. 
The current study aims to investigate the impact of ADF on the intestinal epithelium.  This 
investigation will specifically analyze phenotypic changes in mice, differences in intestinal crypt 
morphology, and changes in proliferation and mRNA levels due to long term ADF exposure.  
Expression of several genes, of which are implicated in intestinal proliferation, will be used to 
explore potential mechanisms by which changes may be occurring as a result of the ADF diet 
regimen.  All segments of the small intestine and colon will be analyzed in the study, with a focus 
on the jejunum, the primary site of intestinal nutrient absorption.  Given previous research showing 
decreased cell proliferation in several tissues from ADF, we hypothesize that ADF will result in 
decreased proliferation in the epithelium leading to changes in gene expression associated with 





MATERIALS AND METHODS 
 
Animals/Diet  
Adult CD-1 mice (8 weeks old) were randomly divided into 2 groups: control and ADF.  The 
control group received standard chow ad libitum, and the ADF group received the same diet given 
every other day.  For a 24-hour period the ADF mice received food ad libitum followed by the 
removal of food during the next 24 hours.  Food was removed and added at the same time every 
day.  Water was given ad libitum for both groups.  Measurements of body weight were performed 
weekly and food intake was recorded by subtracting the weight of the food in the cage from the 
amount of food added in the 24 hours prior to that point.  After 20 weeks on ADF regimen, mice 
were euthanized.  Prior to tissue collection, all ADF mice were euthanized following a 24-hour 
fast period.  Controls were also fasted for the same 24-hour fast period to account for the short 
term impact of fasting. 
Tissue Collection 
All animals were euthanized following a 24-hour fast allowing for comparison between groups.  
Gonadal fat was dissected and weighed.  Small intestine and colon was removed, cleaned and 
flushed prior to measuring weight and length.  Small intestine was divided into three segments, 
the proximal 10 cm was considered duodenum, the distal 10 cm was considered ileum and the 
remaining segment was labeled the jejunum.  Colon was divided in half and labeled proximal and 
distal colon. 
Crypt Cell Count 
H&E (haemotoxylin and eosin) staining of the cross sections of small intestine was performed for 
all animals.  Number of cells in jejunal crypts was counted by H&E staining at 100x magnification.  
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For each animal, 30 open crypts were chosen and the number of nuclei within the crypt was 
counted.  
RNA Extraction and reverse transcription 
Total RNA was extracted from frozen tissue of the small intestine and colon tissue using the 
RNeasy mini kit following homogenization in Lysing Matrix D tubes with RLT Buffer and 1% β-
mercaptoethanol.  Purity and integrity of the extracted RNA was confirmed by electrophoresis in 
agarose gels containing ethidium bromide.  Between 0.5 and 1.0 µg of pure, non-degraded RNA 
were used to synthesize cDNA with the High Capacity cDNA Reverse Transcription kit, including 
RNase inhibitor.  
qRT-PCR 
Platinum Quantitative PCR 2X Supermix –UDG and Taqman primer/probe sets were used to 
perform the quantitative real time polymerase chain reaction (qRT-PCR).  A standard curve was 
made by pooling equal volumes of cDNA from all samples and run in each reaction.  Samples 
were run in duplicates with less than 0.5 Ct of variation to determine gene expression using the 
StepOne Plus Real-Time PCR System.  Expression values were all normalized to the invariant 
control, Tbp.  Primer/probe sets for the following genes were used: TATA binding protein (Tbp), 
insulin-like growth factor 1 (Igf1), insulin receptor (Ir), insulin-like growth factor receptor (Igf1r), 
cyclin D1 (Ccnd1), and proglucagon receptor (Gcg)). 
RT-PCR for insulin receptor isoforms 
RT-PCR for insulin receptor (IR) isoforms was performed using primers that span exon 11 of 
insulin receptor mRNA so both IR isoform A (IR-A) and IR isoform B (IR-B) could be amplified 
in the same reaction.30  Products were run on a 2.5% agarose gel and 2 distinct bands (214bp – IR-
A; 250bp – IR-B) were revealed.  IR-B:IR-A ratios were calculated from values obtained by 
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measuring densitometry using ImageJ software, available through the National Institutes of Health 
(http://rsbweb.nih.gov/ij/).  
Statistical analysis 
Data expressed as mean ± SEM.  A total of 8-9 animals were included in entire study.  For all 
molecular experiments a subset of the animals (n ≥ 3) were included.  Differences between diets 






ADF decreases gonadal fat mass and plasma triglycerides despite no differences in body weight 
compared to controls 
After 20 weeks on the diet, body composition of the animals was assessed.  No differences in body 
weight between control and ADF mice were observed (Fig. 2A).  However, ADF mice had 
significantly decreased gonadal fat mass compared to controls (1.0 ± 0.2g vs. 0.4 ± 0.2g; Fig. 2B-
C).  Plasma triglyceride levels were also significantly decreased in ADF mice compared to controls 
(Fig. 2D). 
Significant decrease in jejunal crypt depth and crypt cell number of ADF group compared to 
controls but no change in villus height 
No difference in jejunal villus height was observed between groups (Fig. 3A).  Jejunal crypt depth 
was measured and shown to be significantly decreased in ADF mice compared to controls (Fig. 
3B & 3D).  This decrease in crypt depth was associated with significant decreases in number of 
cells per crypt in ADF mice versus controls (Fig. 3C & 3D).  
Significant decrease in the number of EdU positive cells in ADF group compared to controls 
To evaluate changes in proliferation, mice were subjected to a 90-minute pulse of EdU prior to 
euthanasia to mark cells in S-phase.  Quantification revealed a significant decrease in the number 
of EdU positive cells in ADF mice versus controls (8.5 ± 0.3 vs. 6.8 ± 0.5; Fig. 3E & 3F).  
No significant change, but trend for decrease in Igf1, Igf1r, Ir, Gcg, and Ccnd1 mRNA in the 
jejunum of ADF group versus fasted controls; Significant increase in IR-B:IR-A ratio in 
jejunum of ADF group versus fasted controls 
 
Gene expression analysis of potential mediators of intestinal proliferation was performed to 
elucidate the underlying mechanism in ADF mice.  Because of its roles in intestinal proliferation 
and nutrition, we wanted to assess if intestines from ADF mice displayed changes in the key genes 
involved in the IGF1/insulin pathway.  Using qRT-PCR, mRNA of the following genes was 
measured in the small intestine and colon: Igf1, Ir, Igf1r, Ccnd1 and Gcg.  All segments of the 
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small intestine were analyzed, however, we concentrated on the jejunum, the primary site of 
intestinal nutrient absorption.  We observed no significant changes, but a trend for decrease in 
mRNA levels in jejunums between groups (Fig. 4A).  The IR has two distinct isoforms, IR-B and 
IR-A, which play counter-regulatory roles in proliferation.30  The mRNA levels of both isoforms 
were measured and a significant increase in the IR-B:IR-A mRNA ratio was found in the jejunum 
of ADF group compared to fasted controls (Fig. 4B & 4C). 
Significant decrease in Igf1, Igf1r, Ir, and Ccnd1 mRNA and increase in IR-B:IR-A ratio in the 
colon of ADF group versus fasted controls 
When we looked at Igf1, Ir, Igf1r, Ccnd1 mRNA levels in the colon, we found drastic decreases 
in Igf1, Ir, Igf1r, and Ccnd1 mRNA of ADF group compared to controls (Fig. 5A-D).  A significant 
increase in the IR-B:IR-A mRNA ratio was also observed in the colon of ADF group compared to 






 ADF has become popular within the last decade, as it has proved to have many similar 
physiological benefits to CR yet with possibly more feasibility as a diet regimen.  In addition to 
those beneficial physiological effects, decreases in cell proliferation in many tissues have been 
observed after treatment with ADF.  However, the impact of ADF on the intestinal epithelium, 
specifically in regards to proliferation, has been unexplored.  As a result, the question addressed 
in the current study was how ADF impacts the intestinal epithelium.  We have shown in the 
intestine that ADF results in decreased jejunal crypt depth and crypt cell number, as well as an 
increased shift towards expression of the IR-B isoform of the insulin receptor, which is anti-
proliferative and promotes differentiated function.30  Results from the colon showed decreased 
expression of important genes in the IGF1/insulin pathway, which promotes intestinal epithelial 
growth. A trend for decrease in those genes was also observed in the small intestine.  With the 
summary of these results we propose that ADF reduces proliferation and promotes differentiated 
function in the intestine, which allows for increased efficiency in harvesting nutrients per unit 
length of the small intestine and protection against tumorigenesis in the colon.  
We observed a significant decrease in crypt depth in jejunum of ADF mice and this was 
associated with similar decreases in crypt cell number, indicating more shallow crypts were due to 
a decrease in cell number. Changes in crypt depth but not in villus height suggests intestines of 
ADF mice may adapt to the diet by decreasing the proliferative compartment without sacrificing 
functional capacity. 
Another impact of the ADF diet regimen on the small intestine was a decrease in the 
number of proliferating cells per crypt.  This was illustrated by the decreased number of cells 
labeled by EdU, which marks all cells in S-phase during the 90 minute pulse in which mice were 
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subjected to it.  This decreased number of proliferating cells may be an adaptation to spare the 
functional cells within the crypt, so that absorption of nutrients can be more efficient when the 
fasting period is over and ad libitum feeding beings.  This decrease in intestinal epithelial cell 
proliferation is supported by previous research which has shown ADF diet regimens, consisting of 
a 24 hour fast and 24 re-feeding regimen over a 4 week time period, promote significant decreases 
in proliferation of epithelial, splenic-T, and mammary epithelial cells.26 
 In the current study, although not significant, we observed a trend for a decrease in key 
genes within the IGF1/insulin pathway in the jejunum.  The analyzed pathway intermediates 
include Igf1, Igf1r, Ir, Gcg, and Ccnd1.  We analyzed the expression of these genes implicated in 
the IGF1/insulin pathway to find possible mechanisms by which ADF resulted in decreased 
intestinal epithelial cell proliferation.  The IGF1/insulin signaling pathway has been shown to play 
a critical role in regulating the growth of the intestinal epithelium, and is affected by changes in 
nutrient status within the intestinal lumen.31, 32  The insulin-like growth factor 1 receptor (Igf1r) is 
highly homologous to the insulin receptor (Ir), allowing both IGF1 and insulin to be able to signal 
through the pathway to proliferation.30  It has also been shown that proglucagon (Gcg) acts through 
IGF1 to promote proliferation,33 and that IGF1 upregulates cyclin D1 (Ccnd1), which forms a 
complex necessary for regulating the progression of the G1 phase of the cell cycle.
34  Further 
research will be done with a larger sample size to observe if there is a significant downregulation 
of these intermediates within the IGF1/insulin pathway in the jejunum of ADF mice. 
 The IR exists in two structurally different isoforms, IR-A and IR-B.  The differing factor 
is the presence (IR-B) or lack (IR-A) of exon 11, located at the C-terminus ligand-binding α-
subunit of the IR.  Recent research suggests IR-A is predominantly expressed in cycling IESC and 
rapidly dividing progenitors, while IR-B is highly expressed in post-mitotic differentiated 
14 
 
lineages.30  As a result, the IR isoforms are thought to modulate proliferation by either promoting 
IR-A or inhibiting IR-B expression.  Because of the importance of the IR isoforms in regulating 
proliferation, their mRNA levels were measured.  While we see no differences in expression in 
total IR, ADF shifts the IR isoform ratio to favor IR-B expression which is anti-proliferative and 
promotes differentiation.30  This shift towards IR-B expression suggests an anti-proliferative effect 
of ADF on the small intestine, as well as an increase in differentiated function.  The combination 
of inhibited proliferation and promoted differentiated function may be an adaptation of the small 
intestine to the ADF regimen, allowing it to maximize its ability to harvest nutrients per unit length, 
while decreasing expenditure of energy on growth.   
 Analysis of gene expression in the colon was surprising in that it showed several significant 
changes of which were not observed in the small intestine.  In the colon, expression of Igf1, Igf1r, 
and Ir, were significantly downregulated compared to controls.  This downregulation of genes in 
the IGF1/insulin pathway in the colon supports the conclusion that ADF has anti-proliferative 
effects on the colon, in addition to the jejunum.  This is also demonstrated by the significant 
increase in the IR-B:IR-A ratio in the colon.  IR-A has been both linked to tumorigenesis and 
shown to be increased in intestinal tumors and colorectal cancer cell lines.30  Therefore, a reduction 
in IR-A may be protective against tumorigenesis in the colon, which is augmented by the increase 
in the anti-proliferative effects of IR-B.30  Decreased expression of Ccnd1 further supports the 
anti-proliferative effects of ADF.  Taken together, our data shows that ADF has a larger effect on 
the colon and may be protective against tumorigenesis.  This may be another similar link between 
ADF and CR, given that several studies have shown CR reduces risk of colon cancers.35, 36 
The results of this study support the preliminary data showing ADF does not result in 
significant changes in body weight compared to controls.  However, significant decreases in 
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gonadal fat and TAG levels in the ADF group were shown.  These differences may suggest changes 
in energy utilization and expenditure between ADF and control mice.  Another possible reason for 
these differences may be related to changes in fat storage due to the microbiome.  Previous 
research, comparing germ-free and conventionally raised mice, has shown gut microbiota act as 
an environmental factor that regulates the storage of fat.37  Further research will be done to analyze 
the impact of ADF on the microbiome.  
 There were some limitations to the study.  The sample size for molecular analysis was 
small (n=3), and may account for why certain changes in gene expression in the small intestine 
were not significant.  However, the drastic significant decreases in the colon with this limited 
number signifies the results seen in the colon are consistently true.  Another limitation was that 
upon completion of the 20 week diet, mice were euthanized after a 24 hour fast.  Changes may 
have been more apparent as different if ADF mice had been euthanized after a day of feeding.  The 
length of the diet is another possible factor that could have affected the results.  Because the 
intestine is so highly adaptive, a shorter length of the diet may have shown more significant 
differences between the treatment and control groups.  Lastly, there were no changes in body 
weight between the treatment and control mice, which may have produced different results than if 
body weight had decreased after treatment.  In one ADF study, circulating levels of IGF1 were 
reported to increase after 20 weeks of treatment,38 yet another study reported a significant decrease 
after 24 weeks of treatment.39  A major difference between these two studies was that animals did 
not lose weight in the 20 week study, yet they did in the 24 week study.  
 In conclusion, the results suggest ADF has anti-proliferative effects and promotes 
differentiated function, which may allow for increased absorptive efficiency per unit length of the 
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small intestine and protection against tumorigenesis, particularly in the colon (Fig. 8).  Future 





Figure 1: Intestinal epithelium is organized into crypts containing stem, Paneth, and progenitor 
cells and villi containing functional differentiated lineages 
Figure 2: ADF decreases gonadal fat mass and plasma triglycerides despite no differences in 
body weight compared to controls. (A) Measurements of body weight over 20 weeks on the 
control or ADF diet. (B) Image of gonadal fat of control and ADF mice. (C) Gonadal fat mass of 
control and ADF groups. (D) Plasma triglyceride levels of control and ADF groups. n≥3 per group; 
*p<0.05 vs. control; unpaired t-test  
Figure 3: Significant decrease in jejunal crypt depth, crypt cell number and number of EdU 
positive cells in ADF group compared to controls. (A) Villus height for control and ADF groups. 
(B) Crypt depth for control and ADF groups. (C) Number of cells in jejunal crypts. (D) Image of 
H&E stained crypts at 10x and 40x (inset). E-F: Immunofluorescence image (E) and quantification 
(F) of EdU (red) and DAPI (blue) reveal significant decrease in number of EdU positive cells in 
ADF mice compared to controls. Images taken at 40x. n≥4 per group; *p<0.05 vs. control; unpaired 
t-test 
Figure 4: No significant changes, but a trend for decrease jejunal mRNAs involved in the 
IGF1/insulin pathway, however, significant shift favoring IR-B:IR-A ratio. (A) qRT-PCR 
measured mRNA levels of Igf1, Igf1r, Ir, Gcg and Ccnd1 for ADF and control groups. 
(B) Representative gel from RT-PCR assessed the ratio of IR-B (top band) and IR-A (bottom band) 
mRNAs using primers spanning exon 11 of the Ir. (C) Quantification of the band intensity reveal 




Figure 5: Significant decrease in Igf1, Igf1r, Ir, and Ccnd1 and an increase in IR-B mRNA in 
the colon of ADF group versus fasted controls. A-D: qRT-PCR measured mRNA levels of Igf1 
(A) Igf1r (B) Ir (C) and Ccnd1 (D) in colons of ADF versus control mice. E-F: Representative gel 
from RT-PCR displaying IR isoform expression in proximal and distal colon (E) and quantification 
of band intensity (F). n=4 per group; *p<0.05 vs. control; unpaired t-test 
Figure 6: Proposed model of ADF effects on small intestine, colon and adipose tissue. ADF 
acts on the intestine to maximize nutrient harvest in the small intestine and to limit intestinal 
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